Charles A. Dinarello
Charles A. Dinarello | |
---|---|
cytokines | |
Awards | Ernst Jung Prize (1993) Crafoord Prize (2009) Albany Medical Center Prize (2009) Paul Ehrlich and Ludwig Darmstaedter Prize (2010) Tang Prize (2020) |
Scientific career | |
Fields | Medicine Immunology |
Institutions | University of Colorado Denver |
Charles A. Dinarello (born April 22, 1943) is a professor of medicine at the
Interleukin 1
.
Education and career
Dinarello received his
interleukin-1.[1] This important step established the validation of cytokines as mediators of disease, particularly of inflammation. Current studies blocking IL-1 in humans supports Dinarello's and his co-workers pivotal contributions to cytokine biology and the pathogenesis of inflammatory diseases.[2]
He is fluent in English, Italian and German.[citation needed]
Awards
- 1993: Ernst Jung Prize
- 2006: Hamdan Award for Medical Research Excellence, awarded by Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, Dubai, United Arab Emirates
- 2009: Crafoord Prize in Polyarthritis (together with Tadamitsu Kishimoto and Toshio Hirano) “for their pioneering work to isolate interleukins, determine their properties and explore their role in the onset of inflammatory diseases”.[3]
- 2009: Bruce A. Beutler)[4]
- 2010: Paul Ehrlich and Ludwig Darmstaedter Prize
- 2010: Novartis Prize in Clinical Immunology (together with Juerg Tschopp).
- 2011: Foreign membership of the Royal Netherlands Academy of Arts and Sciences[5]
- 2020: Tang Prize in Biopharmaceutical Science.[6]
References
- PMID 27226996.
- PMC 3933951.
- ^ Press Release of the Royal Swedish Academy of Sciences Archived July 8, 2011, at the Wayback Machine
- ^ Immune system researchers win $500K medical prize
- ^ "Charles Dinarello". Royal Netherlands Academy of Arts and Sciences. Archived from the original on 29 January 2016. Retrieved 29 January 2016.
- ^ Tang Prize 2020
External links
Wikimedia Commons has media related to Charles A. Dinarello.